Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 367

1.

Adipose tissue depot-specific differences in adipocyte apolipoprotein E expression.

Huang ZH, Espiritu DJ, Uy A, Holterman AX, Vitello J, Mazzone T.

Metabolism. 2011 Dec;60(12):1692-701. doi: 10.1016/j.metabol.2011.04.012. Epub 2011 Jun 12.

2.

Hyperglycemia and advanced glycosylation end products suppress adipocyte apoE expression: implications for adipocyte triglyceride metabolism.

Espiritu DJ, Huang ZH, Zhao Y, Mazzone T.

Am J Physiol Endocrinol Metab. 2010 Oct;299(4):E615-23. doi: 10.1152/ajpendo.00273.2010. Epub 2010 Jul 20.

3.

Angiotensin II regulates adipocyte apolipoprotein E expression.

Rao P, Huang ZH, Mazzone T.

J Clin Endocrinol Metab. 2007 Nov;92(11):4366-72. Epub 2007 Sep 4.

PMID:
17785354
4.

Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo.

Huang ZH, Gu D, Mazzone T.

Am J Physiol Endocrinol Metab. 2009 May;296(5):E1110-9. doi: 10.1152/ajpendo.90964.2008. Epub 2009 Feb 17.

5.

Endogenous ApoE expression modulates adipocyte triglyceride content and turnover.

Huang ZH, Reardon CA, Mazzone T.

Diabetes. 2006 Dec;55(12):3394-402.

6.

Oxidative stress regulates adipocyte apolipoprotein e and suppresses its expression in obesity.

Espiritu DJ, Mazzone T.

Diabetes. 2008 Nov;57(11):2992-8. doi: 10.2337/db08-0592. Epub 2008 Aug 4.

7.

Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation.

Huang ZH, Reardon CA, Getz GS, Maeda N, Mazzone T.

J Lipid Res. 2015 Feb;56(2):215-26. doi: 10.1194/jlr.M050567. Epub 2014 Nov 24.

8.

Mechanism for endogenously expressed ApoE modulation of adipocyte very low density lipoprotein metabolism: role in endocytic and lipase-mediated metabolic pathways.

Huang ZH, Minshall RD, Mazzone T.

J Biol Chem. 2009 Nov 13;284(46):31512-22. doi: 10.1074/jbc.M109.004754. Epub 2009 Sep 18.

9.
10.

Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.

Drolet R, Bélanger C, Fortier M, Huot C, Mailloux J, Légaré D, Tchernof A.

Obesity (Silver Spring). 2009 Mar;17(3):424-30. doi: 10.1038/oby.2008.555. Epub 2008 Dec 11.

11.

In preeclampsia, maternal third trimester subcutaneous adipocyte lipolysis is more resistant to suppression by insulin than in healthy pregnancy.

Huda SS, Forrest R, Paterson N, Jordan F, Sattar N, Freeman DJ.

Hypertension. 2014 May;63(5):1094-101. doi: 10.1161/HYPERTENSIONAHA.113.01824. Epub 2014 Mar 3.

12.

Paired subcutaneous and visceral adipose tissue aquaporin-7 expression in human obesity and type 2 diabetes: differences and similarities between depots.

Miranda M, Escoté X, Ceperuelo-Mallafré V, Alcaide MJ, Simón I, Vilarrasa N, Wabitsch M, Vendrell J.

J Clin Endocrinol Metab. 2010 Jul;95(7):3470-9. doi: 10.1210/jc.2009-2655. Epub 2010 May 12.

PMID:
20463097
13.

Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding.

Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, Rothenberg FG, Neltner B, Romig-Martin SA, Dickson EW, Rudich S, Weintraub NL.

Circ Res. 2009 Feb 27;104(4):541-9. doi: 10.1161/CIRCRESAHA.108.182998. Epub 2009 Jan 2.

14.

Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.

Walker GE, Verti B, Marzullo P, Savia G, Mencarelli M, Zurleni F, Liuzzi A, Di Blasio AM.

Obesity (Silver Spring). 2007 Aug;15(8):1933-43.

15.

Combined gene and protein expression of hormone-sensitive lipase and adipose triglyceride lipase, mitochondrial content, and adipocyte size in subcutaneous and visceral adipose tissue of morbidly obese men.

De Naeyer H, Ouwens DM, Van Nieuwenhove Y, Pattyn P, 't Hart LM, Kaufman JM, Sell H, Eckel J, Cuvelier C, Taes YE, Ruige JB.

Obes Facts. 2011;4(5):407-16. doi: 10.1159/000333445. Epub 2011 Oct 14.

16.

Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice.

Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N.

Int J Obes (Lond). 2008 Oct;32(10):1595-605. doi: 10.1038/ijo.2008.143. Epub 2008 Aug 26.

17.

Depot-specific differences in perilipin and hormone-sensitive lipase expression in lean and obese.

Ray H, Pinteur C, Frering V, Beylot M, Large V.

Lipids Health Dis. 2009 Dec 18;8:58. doi: 10.1186/1476-511X-8-58.

18.

Differences in adipocytokines and fatty acid composition between two adipocyte fractions of small and large cells in high-fat diet-induced obese mice.

Matsubara Y, Kano K, Kondo D, Mugishima H, Matsumoto T.

Ann Nutr Metab. 2009;54(4):258-67. doi: 10.1159/000229506. Epub 2009 Jul 27.

PMID:
19641303
19.

Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese.

Bennetzen MF, Nielsen TS, Paulsen SK, Bendix J, Fisker S, Jessen N, Lund S, Richelsen B, Pedersen SB.

Eur J Clin Invest. 2010 Feb;40(2):121-6. doi: 10.1111/j.1365-2362.2009.02231.x. Epub 2009 Dec 21.

PMID:
20039929
20.

Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice.

Wamil M, Battle JH, Turban S, Kipari T, Seguret D, de Sousa Peixoto R, Nelson YB, Nowakowska D, Ferenbach D, Ramage L, Chapman KE, Hughes J, Dunbar DR, Seckl JR, Morton NM.

Diabetes. 2011 Apr;60(4):1158-67. doi: 10.2337/db10-0830. Epub 2011 Feb 24.

Supplemental Content

Support Center